How do you pay?

How to pay the least

Ask for the cash price

Nyvepria

Nyvepria is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Nyvepria’s cash price, and one or two other pharmacies too.
  2. Nyvepria’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameNyvepria
Authorized genericpegfilgrastim-apgf
Regular genericpegfilgrastim-apgf
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Nyvepria?
The original
–
–

Brand nameThe maker’s card

Pfizer Oncology Together Co-Pay Savings Program for Injectables

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a dose

The card takes up to $4,000–$10,000 a year off your co-pay.

Sign up on pfizercopay.com 

Or call 1-800-555-4820.

In the maker’s words

“as little as $0 per administered dose.”

From the maker’s offer on pfizercopay.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Nyvepria itself, from the same company, sold without the brand name, and usually for less. For now Nyvepria is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Nyvepria is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

NYVEPRIA is a leukocyte growth factor indicated in adults and pediatric patients aged newborn and older to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.

Limitations of Use

NYVEPRIA is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.

Source: the FDA label for Nyvepria (Pfizer Laboratories Div Pfizer Inc), June 2, 2026. Full label on DailyMed 

Good to know